|
1
|
Biddlestone-Thorpe L, Sajjad M, Rosenberg
E, Beckta JM, Valerie NC, Tokarz M, Adams BR, Wagner AF, Khalil A,
Gilfor D, et al: ATM kinase inhibition preferentially sensitizes
p53-mutant glioma to ionizing radiation. Clin Cancer Res.
19:3189–3200. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang SC, Wu CC, Wei YY, Hong JH and Chiang
CS: Inactivation of ataxia telangiectasia mutated gene can increase
intracellular reactive oxygen species levels and alter
radiation-induced cell death pathways in human glioma cells. Int J
Radiat Biol. 87:432–442. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee JH and Paull TT: ATM activation by DNA
double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science.
308:551–554. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shiloh Y: ATM and related protein kinases:
safeguarding genome integrity. Nat Rev Cancer. 3:155–168. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jackson SP: Sensing and repairing DNA
double-strand breaks. Carcinogenesis. 23:687–696. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Squatrito M, Brennan CW, Helmy K, Huse JT,
Petrini JH and Holland EC: Loss of ATM/Chk2/p53 pathway components
accelerates tumor development and contributes to radiation
resistance in gliomas. Cancer Cell. 18:619–629. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vecchio D, Daga A, Carra E, Marubbi D,
Baio G, Neumaier CE, Vagge S, Corvò R, Pia Brisigotti M, Louis
Ravetti J, et al: Predictability, efficacy and safety of
radiosensitization of glioblastoma-initiating cells by the ATM
inhibitor KU-60019. Int J Cancer. 15:479–491. 2014. View Article : Google Scholar
|
|
8
|
Golding SE, Rosenberg E, Adams BR,
Wignarajah S, Beckta JM, O'Connor MJ and Valerie K: Dynamic
inhibition of ATM kinase provides a strategy for glioblastoma
multiforme radiosensitization and growth control. Cell Cycle.
11:1167–1173. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gil del Alcazar CR, Hardebeck MC,
Mukherjee B, Tomimatsu N, Gao X, Yan J, Xie XJ, Bachoo R, Li L,
Habib AA, et al: Inhibition of DNA double-strand break repair by
the dual PI3K/mTOR inhibitor NVP-BEZ235 as a strategy for
radiosensitization of glioblastoma. Clin Cancer Res. 20:1235–1248.
2014. View Article : Google Scholar
|
|
10
|
Zhou W, Sun M, Li GH, Wu YZ, Wang Y, Jin
F, Zhang YY, Yang L and Wang DL: Activation of the phosphorylation
of ATM contributes to radioresistance of glioma stem cells. Oncol
Rep. 30:1793–1801. 2013.PubMed/NCBI
|
|
11
|
Guha C, Guha U, Tribius S, Alfieri A,
Casper D, Chakravarty P, Mellado W, Pandita TK and Vikram B:
Antisense ATM gene therapy: a strategy to increase the
radiosensitivity of human tumors. Gene Ther. 7:852–858. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chuah TL, Walker DG, Wei M, Scott S and
Lavin MF: Approaches to sensitizing glioblastoma to radiotherapy:
use of lentiviral vectors. Int J Oncol. 40:1963–1969.
2012.PubMed/NCBI
|
|
13
|
Nadkarni A, Shrivastav M, Mladek AC,
Schwingler PM, Grogan PT, Chen J and Sarkaria JN: ATM inhibitor
KU-55933 increases the TMZ responsiveness of only inherently TMZ
sensitive GBM cells. J Neurooncol. 110:349–357. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tribius S, Pidel A and Casper D: ATM
protein expression correlates with radioresistance in primary
glioblastoma cells in culture. Int J Radiat Oncol Biol Phys.
50:511–523. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li W, Jian W, Xiaoping X, Yingfeng L, Tao
X and Xiaoyan X: Enhanced radiation-mediated cell killing of human
cervical cancer cells by small interference RNA silencing of ataxia
telangiectasia-mutated protein. Int J Gynecol Cancer. 16:1620–1630.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bernstein JL, Haile RW, Stovall M, Boice
JD Jr, Shore RE, Langholz B, Thomas DC, Bernstein L, Lynch CF,
Olsen JH, et al WECARE Study Collaborative Group: Radiation
exposure, the ATM Gene, and contralateral breast cancer in the
women's environmental cancer and radiation epidemiology study. J
Natl Cancer Inst. 102:475–483. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Poosarla C, Ramesh M, Ramesh K, Gudiseva
S, Bala S and Sundar M: Proliferating cell nuclear antigen in
premalignancy and oral squamous cell carcinoma. J Clin Diagn Res.
9:ZC39–ZC41. 2015.PubMed/NCBI
|
|
18
|
Yang M, Zhai X, Xia B, Wang Y and Lou G:
Long noncoding RNA CCHE1 promotes cervical cancer cell
proliferation via upregulating PCNA. Tumour Biol. 36:7615–7622.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tamm I, Wang Y, Sausville E, Scudiero DA,
Vigna N, Oltersdorf T and Reed JC: IAP-family protein survivin
inhibits caspase activity and apoptosis induced by Fas (CD95), Bax,
caspases, and anticancer drugs. Cancer Res. 58:5315–5320.
1998.PubMed/NCBI
|
|
20
|
Moschos SJ, Dodd NR, Jukic DM, Fayewicz
SL, Wang X and Becker D: Suppressing the high-level expression and
function of ATM in advanced-stage melanomas does not sensitize the
cells to ionizing radiation. Cancer Biol Ther. 8:1815–1825. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sahu U, Sidhar H, Ghate PS, Advirao GM,
Raghavan SC and Giri RK: A novel anticancer agent,
8-methoxypyrimido[4′,5′:4,5] thieno(2,3-b) quinoline-4(3h)-one
induces neuro 2a neuroblastoma cell death through p53-dependent,
caspase-dependent and -independent apoptotic pathways. PLoS One.
8:e664302013. View Article : Google Scholar
|
|
22
|
Liu L, Yim H, Choi JH, Kim ST, Jin Y and
Lee SK: ATM kinase promotes both caspase-8 and caspase-9 activation
during TNF-α-induced apoptosis of HeLa cells. FEBS Lett.
588:929–935. 2014. View Article : Google Scholar : PubMed/NCBI
|
